Insight (American Society Of Ophthalmic Registered Nurses)[JOURNAL]

Multiple sclerosis (MS) is an immune-mediated dis- ease of the central nervous system. It is diagnosed most often in persons between the ages of 20 and 40 years. The effects of this disease can be numerous, and for some... Multiple sclerosis (MS) is an immune-mediated dis- ease of the central nervous system. It is diagnosed most often in persons between the ages of 20 and 40 years. The effects of this disease can be numerous, and for some individuals it can be very disabling. Fortunately, there arenow many disease-modifying medications to treat persons who have a relapsing form of MS. Visual symptoms are among the many symptoms of MS. The most common visual condition is optic neuritis (ON), occurring in up to 50% of persons as the first symptom of MS (Abou Zeid & Bhetti, 2008; Jacobs et al., 2000; Kappos et al., 2006). This article highlights symptoms, assessment, diagnosis, treatment, and outcomes of ON. Implications for collaboration across spe- cialties are also discussed.

Get PDF PubMed ↗

Veronica Arellano RN, BSN, CRNO, CLNC.

Durbin LJ

Insight · 2016 · PMID 27209692

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Racing Kona: Blind Triathlete Fulfills Childhood Dream.

Patterson CE

Insight · 2016 · PMID 27209691

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Brain Trauma and Vision Problems.

Cakiner-Egilmez T

Insight · 2016 · PMID 27209690

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

The ADA and Its Amendment. Impact on All Nurses.

Neal-Boylan L, Miller M

Insight · 2016 · PMID 27209689

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Improving Healthcare Experiences for Visually Impaired Service Members and Veterans: A Multidisciplinary Joint Agency Collaboration.

Egan JA

Insight · 2016 · PMID 27209688

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Just Another Trauma Case in the Ophthalmic Emergency Room.

Bacon MM

Insight · 2016 · PMID 27209687

Abstract loading — click title to view on PubMed.

Get PDF PubMed ↗

Ocular Pharmacology.

Rehovsky J

Insight · 2016 · PMID 27209686

Medications are a common treatment for glaucoma. Pharmacologic agents include sympathomimetics, beta-blockers, miotics (direct acting and cholinesterase inhibitors), carbonic anhydrase inhibitors, and prostaglandin agoni... Medications are a common treatment for glaucoma. Pharmacologic agents include sympathomimetics, beta-blockers, miotics (direct acting and cholinesterase inhibitors), carbonic anhydrase inhibitors, and prostaglandin agonists. Other agents include hyperosmotic agents and nonsteroidal anti-inflammatory drugs. Members of the ophthalmic health-care team, with heightened attention to patient safety, prescribe, administer, monitor side effects, and educate patients on glaucoma medications.

Get PDF PubMed ↗

A Role for Children in Health Research.

Dellert JC

Insight · 2016 · PMID 27209685

Children are not passive recipients of knowledge but active creators of their own understandings of their world (Hampshire et al., 2012). The competent child has a right to full participation in research as in other area... Children are not passive recipients of knowledge but active creators of their own understandings of their world (Hampshire et al., 2012). The competent child has a right to full participation in research as in other areas of their lives, with full value in the present, not just as a future adult citizen (Quennerstedt, 2013). While research studies with child participants demand additional considerations, there is great potential for notable impacts on the lives and well-being of children.

Get PDF PubMed ↗

Retinal Imaging: Past, Present, and Future.

Landry DA

Insight · 2016 · PMID 27209684

Summary The field of retinal imaging has grown in leaps and bounds over the past 10 years. As these new technologies allow us to visualize different pathologies and anatomy, it is critical that we take the time to establ... Summary The field of retinal imaging has grown in leaps and bounds over the past 10 years. As these new technologies allow us to visualize different pathologies and anatomy, it is critical that we take the time to establish a consensus on what is normal, in order to define what is abnormal. We might consider how this technology affects the diagnosis and treatment of eye disorders and diseases, and ultimately, most importantly, the patient.

Get PDF PubMed ↗